Frontlight ResearchEarly access
Head and neck cancer trials in United States
391 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
- Where
- Chicago, Fairfax, Fullerton, Hackensack, Los Angeles, Louisville, New Haven, Scottsdale
- Age
- 18 years and over
- People
- 235 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT06747585 · EU 2024-515459-39-00 - Phase 1/2Taking peopleA Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Where
- Austin, Boston, Cleveland, Duarte, Fairfax, Houston, Huntersville, Irvine, Milwaukee, Nashville, Omaha, Orlando, Rochester, San Antonio, St Louis, West Valley City, Zion
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Terremoto Biosciences Inc.
See details and how to joinNCT07109726 - Phase 1Taking peoplePembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 6
- Run by
- Thomas Jefferson University
See details and how to joinNCT07501650 - Phase 2Not yet taking people in United StatesAspirin and PAClitaxel in Head & Neck Squamous Cell Carcinoma
- Where
- St Louis
- Age
- 18 years and over
- People
- 40
- Run by
- Washington University School of Medicine
See details and how to joinNCT07901803 - Phase 1Taking peopleSafety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia
- Where
- Minneapolis, New York
- Age
- 18 years and over
- People
- 80
- Run by
- Rockefeller University
See details and how to joinNCT07901959 - Phase 3Taking peopleComparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin
- Where
- Albuquerque, Ames, Anaheim, Ann Arbor, Antigo, Atlanta, Baldwin Park, Bay Pines, Bellflower, Bemidji, Bend, Beverly Hills, Birmingham, Bismarck, Bloomington, Brewer, Brighton, Canandaigua, Canton, Cape Girardeau, Carthage, Cedar Rapids, Chadds Ford, Charleston, Chelsea, Chicago, Cincinnati, Clackamas, Clive, Dansville, Danville, Decatur, DeKalb, Des Moines, Dickson City, Effingham, Eureka, Fargo, Fontana, Galesburg, Geneva, Glenview, Grayslake, Harbor City, Hershey, Houston, Irvine, Johnson Creek, Kansas City, Kewanee, Lake Forest, Lansing, Lawrence, Lee's Summit, Lewisburg, Lexington, Livonia, Los Angeles, Louisville, Macomb, Madison, Mattoon, Menomonee Falls, Milwaukee, Morgantown, Nashville, Newark, Newberg, New Berlin, Oak Brook, Oak Creek, O'Fallon, Oklahoma City, Ontario, Oregon City, Orland Park, Ottawa, Overland Park, Palo Alto, Panorama City, Pekin, Peoria, Peru, Philadelphia, Portland, Princeton, Rhinelander, Richmond, Riverside, Rochester, Rockford, Salina, San Diego, San Jose, San Marcos, Sioux Falls, Stevens Point, Stony Brook, Sylvania, The Bronx, Toledo, Topeka, Urbana, Warrenville, Washington, Wausau, Webster, West Bend, West Chester, West Des Moines, Westwood, Wilkes-Barre, Wilmington, Wisconsin Rapids, Woodland Hills, Ypsilanti
- Age
- 18 years and over
- People
- 454
- Run by
- NRG Oncology
See details and how to joinNCT07441681 - Phase 2Taking peopleA Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Where
- Duarte, Newnan
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- AbbVie
See details and how to joinNCT07744126 · EU 2025-524179-22-00 - Phase 1Taking peopleTMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell Carcinoma
- Where
- Houston
- Age
- 18 years and over
- People
- 30
- Run by
- Metaclipse Therapeutics Corporation
See details and how to joinNCT07898124 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amarillo, Chattanooga, Dallas, Fairfax, Germantown, Los Angeles, Minneapolis, Nashville, New York, Pearland, Salt Lake City, Skokie, Wenatchee, Westbury, White Plains, Whittier
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 2Taking peopleTesting Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
- Where
- Atlanta, Cincinnati, Hackensack, Irvine, Los Angeles, New Orleans, Orange, Pittsburgh, Portland, Richmond, West Chester
- Age
- 18 years and over
- People
- 44
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06980038 - Phase 2Taking peopleTesting the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
- Where
- Ankeny, Ann Arbor, Atlanta, Baton Rouge, Brewer, Brighton, Camden, Chapel Hill, Charleston, Charlotte, Chicago, City of Saint Peters, Clackamas, Clive, Concord, Council Bluffs, Creve Coeur, Danville, DeKalb, Des Moines, Detroit, Effingham, Erie, Farmington Hills, Farrell, Geneva, Glenview, Grayslake, Gresham, Indiana, Irvine, Jackson, Jefferson Hills, Jersey City, Johnson Creek, Johnstown, Kansas City, La Crosse, Lake Forest, Lebanon, Lee's Summit, Lisle, Livingston, Long Branch, Los Angeles, Madison, Mattoon, Menomonee Falls, Milwaukee, Monroeville, Nashville, Newark, Newberg, New Berlin, New Brunswick, Oak Brook, Oak Creek, Oklahoma City, Omaha, Orange, Oregon City, Orland Park, Overland Park, Palo Alto, Philadelphia, Pittsburgh, Portland, Rochester, Sacramento, Seneca, Shiloh, St Louis, Stony Brook, Sylvania, Toms River, Tualatin, Tucson, Urbana, Vancouver, Warrenville, Washington, Waukee, Webster, West Bend, Westwood, Wexford, Willow Grove
- Age
- 18 years and over
- People
- 180
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07195734 - Phase 1Taking peoplePhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
- Where
- Boston, Fairfax, Irving, Lubbock, Oklahoma City, Orlando
- Age
- 18 years and over
- People
- 285
- Run by
- Sutro Biopharma, Inc.
See details and how to joinNCT07807345 - No phaseTaking peopleA Motion Exergaming Approach for Symptom Management: HNC
- Where
- Birmingham
- Age
- 18 years and over
- People
- 150
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT04632654 - Phase 2Taking peopleA Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Where
- Atlanta, Columbus, Detroit, Edgewood, Evanston, Fairfax, Knoxville, Los Angeles, Louisville, Lubbock, Nashville, Omaha, Orlando, Richmond, Rochester, The Woodlands, Willow Grove
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06769698 · EU 2024-517620-19-00 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Atlanta, Austin, Canton, Celebration, Charleston, Cincinnati, Dallas, Dayton, Detroit, Fairfax, Greenville, Las Vegas, Los Angeles, Louisville, Margate, Nashville, New York, Orlando, Plantation, Saint Paul, Santa Monica, Spokane, Tamarac, Tucson
- Age
- 18 years and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - Phase 1/2Taking peopleIntratumoral N17350 in Advanced Solid Tumors
- Where
- Buffalo, Houston, Los Angeles, San Diego, San Francisco
- Age
- 18 years and over
- People
- 275 worldwide
- Run by
- Onchilles Pharma Inc
See details and how to joinNCT07339176 - No phaseTaking peopleGeriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family Caregivers
- Where
- Duarte
- Age
- 18 years and over
- People
- 36
- Run by
- City of Hope Medical Center
See details and how to joinNCT07225855 - Phase 2Taking peoplePD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
- Where
- Boston
- Age
- 18 years and over
- People
- 25
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06239220 - Phase 2Taking peoplePDT For Induction Therapy For Head And Neck Cancer
- Where
- Boston
- Age
- 18 years and over
- People
- 26
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07214987 - Phase 2Taking peopleImmunotherapy and Nodal-Sparing Irradiation for T-Cell Induction and Unmasking of Tumor Antigenicity in the Microenvironment for Head and Neck Cancer
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 20
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07773987 - Phase 2Not yet taking people in United StatesHead and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse
- Where
- Oklahoma City
- Age
- 18 years to 99 years
- People
- 62
- Run by
- University of Oklahoma
See details and how to joinNCT06660017 - Phase 2Taking peopleWindow of Opportunity in Preserving Laryngeal Function Trial
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 87
- Run by
- Matthew Spector
See details and how to joinNCT07423078 - Phase 1Taking peopleSafety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
- Where
- Nashville
- Age
- 18 years and over
- People
- 40
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT07460765 - Phase 1Taking peopleA Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Huntersville, Irving
- Age
- 18 years and over
- People
- 130
- Run by
- AbbVie
See details and how to joinNCT07807956 · EU 2026-526097-17-00 - Phase 2Taking peopleCandida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
- Where
- Fayetteville, Little Rock, Mineola, New York, Rogers, Springdale
- Age
- 18 years to 100 years
- People
- 100
- Run by
- University of Arkansas
See details and how to joinNCT05952934